Nurse Practitioner Program year 2023 Reported 2022–2023 Source: CMS Open Payments, 2026 publication

Jennifer Atkinson

Nurse Practitioner Jackson, MS Nurse Practitioner

NPI 1932877925 CMS profile 10924474

971 Lakeland Dr Ste 950, Jackson, MS 39216

Open in the dashboard

General payments

$2,531

146 records reported · program years 2022–2023

Research payments

$0

Paid to them · None reported · program years 2022–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Jennifer Atkinson of Jackson, MS is reported in the CMS Open Payments database as having received $2,531 across 146 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $594 34
2022 General $1,937 112

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Atkinson
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Jennifer Atkinson were reported at $0. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Jennifer Atkinson Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $0 $135 $40–$426 $132
2022 $1,937 $152 $48–$470 $149
2023 $594 $166 $54–$529 $160
2024 $0 $173 $55–$556 $164
2025 $0 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2022–2023
  1. Amgen Inc. $1,081 60 payments
  2. AbbVie, Inc. $594 36 payments
  3. UCB, Inc. $184 13 payments
  4. Novartis Pharmaceuticals Corporation $140 8 payments
  5. Aurinia Pharma U.S., Inc. $126 6 payments
  6. AstraZeneca Pharmaceuticals LP $122 7 payments
  7. Genentech USA, Inc. $111 6 payments
  8. Janssen Biotech, Inc. $107 7 payments
  9. ANI Pharmaceuticals, Inc. $31 1 payment
  10. Mallinckrodt Hospital Products Inc. $24 1 payment
  11. Other $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2023
  1. Food and Beverage $2,531 146 payments
Products named General payments · program years 2022–2023
  1. Enbrel Inflammation $681 40 payments
  2. Otezla $625 31 payments
  3. RINVOQ $549 33 payments
  4. Cimzia $184 13 payments
  5. Enbrel Inflammation $156 12 payments
  6. LUPKYNIS $126 6 payments
  7. SIMPONI ARIA $107 7 payments
  8. TREMFYA $107 7 payments
  9. EVENITY $94 6 payments
  10. Prolia $94 6 payments
  11. Other $492 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

146 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record